Cover Story
FreeNews Analysis
By Matthew Bin Han Ong
Now that Joseph R. Biden Jr. is inaugurated and safely ensconced in the White House, cancer groups expect him to pick up where he left off as vice president four years ago—pursuing a sober and ambitious agenda for accelerating progress in cancer research.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- Cullen Taniguchi, radiation oncologist at MD Anderson, dies at 47
- Trump 2016: A look back at the 45th president’s impact on oncology
- Should you eat a kielbasa tonight?
Six experts weigh evidence on papers debunking nutritional guidelines on red and processed meat - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”